Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory conditions including, serious lung infections, pulmonary hypertension and gaseous NO for the treatment of solid tumors. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM) and COVID-19. Beyond Air have also developed a proprietary system for delivering gaseous nitric oxide at high concentrations to treat solid tumors.
Surgical Appliance and Supplies Manufacturing (339113)
Surgical & Medical Instruments & Apparatus (3841)